Contractura de Dupuytren: nuevos aspectos en el manejo terapéutico
Abstract
Dupuytren’s contracture (DC) is a fibroproliferative disease of the palmar fascia that results in the thickening and shortening of the normal fibrous bands of the hands and the fingers, producing deformity and dysfunction of the affected hand. Despite being benign, the disease is progressive and may be incapacitating in many aspects. The cause of DC remains a mystery, initially Dupuytren suggested that it may be due to local trauma, and to date some research has confirmed this hypothesis while other appears to deny it. Given the uncertainty in the origin of this disease, it is difficult to find therapeutic targets. Although for a long time surgical options have been the most viable, at present, novel less invasive alternatives are also being considered. The objective of this review is to assess the therapeutic aspects developed for the management of DC and how they compare to the more traditional methods.
Downloads
References
Elliot D. The early history of Dupuytren’s disease. Hand Clin. febrero de 1999;15(1):1-19.
Dupuytren G. De la retraction des doigts par suite d’une affection de l’aponevrose palmaire description de la maladie operation Chirugicale qui con-vient dens de cas. J Univ Hebd Med Chir Prat Inst Med. 1831;5:349-65.
Ross DC. Epidemiology of Dupuytren’s disease. Hand Clin. febrero de 1999;15(1):53-62.
Saboeiro AP, Porkorny JJ, Shehadi SI, Virgo KS, Johnson FE. Racial distribution of Dupuytren’s disease in Department of Veterans Affairs patients. Plast Reconstr Surg. julio de 2000;106(1):71-5.
Mikklesen O. Epidemiology of a Norwegian population. En: Dupuytren’s disease. First ed. Singapore; 1990. p. 191-200.
Early P. Population studies in dupuytren’s contracture. J Bone Joint Surg Br. 1962;44-B:602-13.
Noble J, Arafa M, Royle SG, McGeorge G, Crank S. The association between alcohol, hepatic pathology and Dupuytren’s disease. J Hand Surg Br. febrero de 1992;17(1):71-4.
Burge P, Hoy G, Regan P, Milne R. Smoking, alcohol and the risk of Dupuytren’s contracture. J Bone Joint Surg Br. marzo de 1997;79(2):206-10.
Walthall J, Anand P, Rehman UH. Dupuytren Contracture. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [citado 9 de enero de 2022]. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK526074/
Townley WA, Baker R, Sheppard N, Grobbelaar AO. Dupuytren’s contracture unfolded. BMJ: British Medical Journal. 18 de febrero de 2006;332(7538):397-400.
Layton T, Nanchahal J. Recent advances in the understanding of Dupuytren’s disease. F1000Research. 2019;8:F1000 Faculty Rev-231.
Gudmundsson KG, Arngrimsson R, Jónsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren’s disease. Scand J Rheumatol. 2001;30(1):31-4.
Boe C, Blazar P, Iannuzzi N. Dupuytren Contractures: An Update of Recent Literature. The Journal of Hand Surgery. octubre de 2021;46(10):896-906.
Kadhum M, Smock E, Khan A, Fleming A. Radiotherapy in Dupuytren’s disease: a systematic review of the evidence. J Hand Surg Eur Vol. septiembre de 2017;42(7):689-92.
Mella JR, Guo L, Hung V. Dupuytren’s Contracture: An Evidence Based Review. Ann Plast Surg. diciembre de 2018;81(6S Suppl 1):S97-101.
Lauritzson A, Atroshi I. Collagenase injections for Dupuytren’s disease: prospective cohort study assessing 2-year treatment effect durability. BMJ Open. 15 de marzo de 2017;7(3):e012943.
Needle or Open Fasciotomy for Dupuytren’s Contracture: A Review of the Comparative Efficacy, Safety, and Cost-Effectiveness – An Update [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 [citado 9 de enero de 2022]. (CADTH Rapid Response Reports). Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK195701/
Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. mayo de 2011;36(5):936-42.
Gelman S, Schlenker R, Bachoura A, Jacoby SM, Lipman J, Shin EK, et al. Minimally invasive partial fasciectomy for Dupuytren’s contractures. Hand (New York, NY). diciembre de 2012;7(4):364-9.
Selles RW, Zhou C, Kan HJ, Wouters RM, van Nieuwenhoven CA, Hovius SER. Percutaneous Aponeurotomy and Lipofilling versus Limited Fasciectomy for Dupuytren’s Contracture: 5-Year Results from a Randomized Clinical Trial. Plast Reconstr Surg. diciembre de 2018;142(6):1523-31.
Sambuy MTC, Nakamoto HA, Bolliger R, Mattar R, Rezende MR, Wei TH. Randomized Controlled Trial of Limited Fasciotomy With Injection of Adipose Graft for Dupuytren’s Disease. Acta Ortop Bras. agosto de 2020;28(4):159-64.
Kemler MA, Houpt P, van der Horst CM a. M. A pilot study assessing the effectiveness of postoperative splinting after limited fasciectomy for Dupuytren’s disease. J Hand Surg Eur Vol. octubre de 2012;37(8):733-7.
Werker PMN, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am. octubre de 2012;37(10):2095-2105.e7.
Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD, Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group; What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health. diciembre de 2007;10 Suppl 2:S94-105.
Gummesson C, Atroshi I, Ekdahl C. The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord. 16 de junio de 2003;4:11.
Downloads
Published
Versions
- 2023-04-16 (3)
- 2023-04-16 (2)
- 2023-02-11 (1)
